Molecular cloning of duck CD40 and its immune function research

[1]  S. Alexander,et al.  Dendritic cell‐targeted CD40 DNA vaccine suppresses Th17 and ameliorates progression of experimental autoimmune glomerulonephritis , 2019, Journal of leukocyte biology.

[2]  G. Ullenhag,et al.  First‐in‐human study with intratumoral administration of a CD40 agonistic antibody, ADC‐1013, in advanced solid malignancies , 2019, International journal of cancer.

[3]  Y. Ishii,et al.  Combination therapy of an iNKT cell ligand and CD40–CD154 blockade establishes islet allograft acceptance in nonmyeloablative bone marrow transplant recipients , 2019, Acta Diabetologica.

[4]  Ye Zhang,et al.  Novel Combination Oncolytic Adenoviral Gene Therapy Armed with Dm-dNK and CD40L for Breast Cancer. , 2019, Current gene therapy.

[5]  James M. Boyer,et al.  Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy , 2018, Cancer Immunology, Immunotherapy.

[6]  M. Fawzy,et al.  The association of CD40 polymorphism (rs1883832C/T) and soluble CD40 with the risk of systemic lupus erythematosus among Egyptian patients , 2018, Clinical Rheumatology.

[7]  T. Wild,et al.  CD40/CD40 ligand interactions and TNFα treatment reduce activity of P105 promoter of the human papilloma virus-18 in vitro. , 2016, Experimental oncology.

[8]  R. Jia,et al.  Identification and molecular characterization of a novel duck Tembusu virus isolate from Southwest China , 2015, Archives of Virology.

[9]  G. Sourvinos,et al.  CD40 ligand exhibits a direct antiviral effect on Herpes Simplex Virus type-1 infection via a PI3K-dependent, autophagy-independent mechanism. , 2015, Cellular signalling.

[10]  Eugene Y. Kim,et al.  Role of sphingosine kinase 1 and sphingosine‐1‐phosphate in CD40 signaling and IgE class switching , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  B. Moss,et al.  CD40L-Adjuvanted DNA/Modified Vaccinia Virus Ankara Simian Immunodeficiency Virus SIV239 Vaccine Enhances SIV-Specific Humoral and Cellular Immunity and Improves Protection against a Heterologous SIVE660 Mucosal Challenge , 2014, Journal of Virology.

[12]  A. Pedersen,et al.  Anti-CD40-mediated cancer immunotherapy: an update of recent and ongoing clinical trials , 2014, Immunopharmacology and immunotoxicology.

[13]  E. Hildt,et al.  CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c‐jun N terminal kinase activation independent from the interferon pathway , 2013, Hepatology.

[14]  J. Xiang,et al.  A novel T cell-based vaccine capable of stimulating long-term functional CTL memory against B16 melanoma via CD40L signaling , 2012, Cellular and Molecular Immunology.

[15]  R. Jia,et al.  Complete Genomic Sequence of Chinese Virulent Duck Enteritis Virus , 2012, Journal of Virology.

[16]  Julia Jellusova,et al.  Signaling by the tumor necrosis factor receptor superfamily in B‐cell biology and disease , 2011, Immunological reviews.

[17]  R. Jia,et al.  Establishment of real-time quantitative reverse transcription polymerase chain reaction assay for transcriptional analysis of duck enteritis virus UL55 gene , 2011, Virology Journal.

[18]  S. Quezada,et al.  CD40/CD154 interactions at the interface of tolerance and immunity. , 2004, Annual review of immunology.

[19]  Patrick André,et al.  Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. , 2002, Circulation.

[20]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[21]  J. Banchereau,et al.  CD40‐CD40 ligand , 2000, Journal of leukocyte biology.

[22]  H. Spits,et al.  A New Mechanism of NK Cell Cytotoxicity Activation: The CD40–CD40 Ligand Interaction , 1997, The Journal of experimental medicine.

[23]  E. Clark,et al.  Functional CD40 ligand expressed by human blood dendritic cells is up-regulated by CD40 ligation. , 1996, Journal of immunology.

[24]  D. Gray,et al.  Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40-CD40 ligand interaction , 1994, The Journal of experimental medicine.

[25]  N. Yoshida,et al.  The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. , 1994, Immunity.

[26]  I. Stamenkovic,et al.  A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[27]  E. Clark,et al.  Molecular and biological characterization of a murine ligand for CD40 , 1992, Nature.

[28]  T. Kawai,et al.  Addition of Anti-CD40 Monoclonal Antibody to Nonmyeloablative Conditioning With Belatacept Abrogated Allograft Tolerance Despite Induction of Mixed Chimerism , 2019, Transplantation.

[29]  B. Moss,et al.  CD 40 L-Adjuvanted DNA / Modified Vaccinia Virus Ankara Simian Immunodeficiency Virus SIV 239 Vaccine Enhances SIV-Specific Humoral and Cellular Immunity and Improves Protection against a Heterologous SIVE 660 Mucosal Challenge , 2022 .